Table 3 - NHP used for different purposes
See below for description of categories
Species |
2.2 |
2.3 |
2.4 |
2.6 |
2.7 |
2.8 |
2.9 |
Total |
Prosimians |
384 |
0 |
0 |
97 |
0 |
0 |
196 |
677 |
NW primates |
357 |
327 |
43 |
650 |
16 |
5 |
166 |
1564 |
OW primates |
715 |
654 |
373 |
6257 |
0 |
37 |
174 |
8210 |
Total |
1456 |
981 |
416 |
7004 |
16 |
42 |
536 |
10451 |
% of the total NHPs used |
13.9 % |
9.38 % |
7.9 % |
67 % |
0.15 % |
0.41 % |
5.1 % |
|
% with respect to total animal used |
0.036 % |
0.026 % |
0.029 % |
0.68 % |
0.008 % |
0.21 % |
0.054 % |
0.09 % |
The six categories defined for use of animals in experimental purposes in Europe are the
following:
- Biological studies of a fundamental nature (2.2)
- Research, development and quality control of products (2.3) and devices for
human medicine (2.3), dentistry (2.4) and for veterinary medicine (2.5)
- Toxicological and other safety evaluations, including safety evaluation of products
(2.6)
- Diagnosis of disease (2.7)
- Education and training (2.8)
- Other (2.9)
[Note: NHP = non-human primates; NW Primates = New World Monkeys; OW Primates = Old World Monkeys More...]
Source:
SCHER,
The need for non-human primates in biomedical research, production and testing of products and devices (2009),
Section 3.1.1 Overview on the use of NHPs in research and testing, p. 7 -11.